(MRB) Mirbud - Ratings and Ratios
Construction,Engineering,Infrastructure,Buildings
MRB EPS (Earnings per Share)
MRB Revenue
Description: MRB Mirbud
Mirbud SA (MRB) is a Polish construction and engineering company listed on the Warsaw Stock Exchange. As a construction and engineering firm, its performance is closely tied to the overall health of the construction sector, which is influenced by factors such as government infrastructure spending, private investment in construction projects, and economic growth.
The companys market capitalization stands at approximately 1.585 billion PLN, with a price-to-earnings ratio of 15.32, suggesting a moderate valuation relative to its earnings. The return on equity (RoE) is 9.66%, indicating a decent level of profitability in terms of shareholder equity. However, the forward P/E ratio is not available, which could be due to a lack of analyst estimates or other factors.
Key economic drivers for Mirbud SA include the Polish governments infrastructure plans, the overall state of the European construction market, and the companys ability to secure new contracts. Key performance indicators (KPIs) to watch for Mirbud SA include revenue growth, order backlog, and profit margins, as these will provide insight into the companys operational performance and its ability to generate cash flows.
From a trading perspective, the stocks beta of 1.562 indicates that it is more volatile than the overall market, suggesting that investors should be prepared for potentially larger price swings. The current price is near its 20-day simple moving average (SMA20), indicating a potential support level, while the longer-term SMAs (SMA50 and SMA200) suggest an overall uptrend.
MRB Stock Overview
| Market Cap in USD | 424m |
| Sub-Industry | Construction & Engineering |
| IPO / Inception |
MRB Stock Ratings
| Growth Rating | 88.7% |
| Fundamental | 38.9% |
| Dividend Rating | 39.1% |
| Return 12m vs S&P 500 | 1.63% |
| Analyst Rating | - |
MRB Dividends
| Dividend Yield 12m | 0.74% |
| Yield on Cost 5y | 4.61% |
| Annual Growth 5y | 60.04% |
| Payout Consistency | 41.6% |
| Payout Ratio | 10.7% |
MRB Growth Ratios
| Growth Correlation 3m | 70.4% |
| Growth Correlation 12m | 82% |
| Growth Correlation 5y | 88.8% |
| CAGR 5y | 64.82% |
| CAGR/Max DD 3y | 2.18 |
| CAGR/Mean DD 3y | 7.28 |
| Sharpe Ratio 12m | -2.41 |
| Alpha | 5.87 |
| Beta | 0.628 |
| Volatility | 39.42% |
| Current Volume | 83.2k |
| Average Volume 20d | 97.4k |
| Stop Loss | 13.5 (-3.3%) |
| Signal | -1.60 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (103.2m TTM) > 0 and > 6% of Revenue (6% = 180.4m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -7.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.15% (prev 20.77%; Δ 10.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -76.3m <= Net Income 103.2m (YES >=105%, WARN >=100%) |
| Net Debt (200.2m) to EBITDA (131.5m) ratio: 1.52 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (110.1m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 7.85% (prev 10.56%; Δ -2.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 123.9% (prev 159.0%; Δ -35.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.65 (EBITDA TTM 131.5m / Interest Expense TTM 28.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.09
| (A) 0.36 = (Total Current Assets 1.73b - Total Current Liabilities 788.7m) / Total Assets 2.60b |
| (B) 0.27 = Retained Earnings (Balance) 688.1m / Total Assets 2.60b |
| (C) 0.05 = EBIT TTM 131.5m / Avg Total Assets 2.43b |
| (D) 0.47 = Book Value of Equity 688.1m / Total Liabilities 1.48b |
| Total Rating: 4.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 38.86
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield -8.27% = -4.14 |
| 3. FCF Margin -4.78% = -1.79 |
| 4. Debt/Equity 0.28 = 2.46 |
| 5. Debt/Ebitda 2.42 = -0.80 |
| 6. ROIC - WACC 0.70% = 0.88 |
| 7. RoE 9.46% = 0.79 |
| 8. Rev. Trend -23.67% = -1.18 |
| 9. Rev. CAGR -9.64% = -1.61 |
| 10. EPS Trend -29.90% = -0.75 |
| 11. EPS CAGR -30.66% = -2.50 |
What is the price of MRB shares?
Over the past week, the price has changed by -3.72%, over one month by -6.68%, over three months by +5.89% and over the past year by +20.18%.
Is Mirbud a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MRB is around 19.03 PLN . This means that MRB is currently undervalued and has a potential upside of +36.32% (Margin of Safety).
Is MRB a buy, sell or hold?
What are the forecasts/targets for the MRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.3 | -54.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21 | 50.2% |
MRB Fundamental Data Overview
Market Cap PLN = 1.54b (1.54b PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 117.4m PLN (Cash only, last quarter)
P/E Trailing = 14.8511
P/S = 0.4954
P/B = 1.3721
Beta = 1.626
Revenue TTM = 3.01b PLN
EBIT TTM = 131.5m PLN
EBITDA TTM = 131.5m PLN
Long Term Debt = 240.2m PLN (from longTermDebt, last quarter)
Short Term Debt = 77.3m PLN (from shortLongTermDebt, last quarter)
Debt = 317.6m PLN (Calculated: Short Term 77.3m + Long Term 240.2m)
Net Debt = 200.2m PLN (from netDebt column, last quarter)
Enterprise Value = 1.74b PLN (1.54b + Debt 317.6m - CCE 117.4m)
Interest Coverage Ratio = 4.65 (Ebit TTM 131.5m / Interest Expense TTM 28.3m)
FCF Yield = -8.27% (FCF TTM -143.7m / Enterprise Value 1.74b)
FCF Margin = -4.78% (FCF TTM -143.7m / Revenue TTM 3.01b)
Net Margin = 3.43% (Net Income TTM 103.2m / Revenue TTM 3.01b)
Gross Margin = 7.85% ((Revenue TTM 3.01b - Cost of Revenue TTM 2.77b) / Revenue TTM)
Tobins Q-Ratio = 2.52 (Enterprise Value 1.74b / Book Value Of Equity 688.1m)
Interest Expense / Debt = 2.00% (Interest Expense 6.36m / Debt 317.6m)
Taxrate = 20.01% (30.4m / 151.7m)
NOPAT = 105.2m (EBIT 131.5m * (1 - 20.01%))
Current Ratio = 2.19 (Total Current Assets 1.73b / Total Current Liabilities 788.7m)
Debt / Equity = 0.28 (Debt 317.6m / last Quarter total Stockholder Equity 1.12b)
Debt / EBITDA = 2.42 (Net Debt 200.2m / EBITDA 131.5m)
Debt / FCF = -2.21 (Debt 317.6m / FCF TTM -143.7m)
Total Stockholder Equity = 1.09b (last 4 quarters mean)
RoA = 3.98% (Net Income 103.2m, Total Assets 2.60b )
RoE = 9.46% (Net Income TTM 103.2m / Total Stockholder Equity 1.09b)
RoCE = 9.88% (Ebit 131.5m / (Equity 1.09b + L.T.Debt 240.2m))
RoIC = 7.88% (NOPAT 105.2m / Invested Capital 1.33b)
WACC = 7.18% (E(1.54b)/V(1.85b) * Re(8.33%)) + (D(317.6m)/V(1.85b) * Rd(2.00%) * (1-Tc(0.20)))
Shares Correlation 3-Years: -39.53 | Cagr: -0.00%
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -143.7m)
Revenue Correlation: -23.67 | Revenue CAGR: -9.64%
Rev Growth-of-Growth: -21.23
EPS Correlation: -29.90 | EPS CAGR: -30.66%
EPS Growth-of-Growth: -48.93